Concepts (86)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Estrogen Receptor beta | 3 | 2025 | 14 | 2.140 |
Why?
|
| Estrogen Receptor alpha | 3 | 2025 | 27 | 2.130 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2025 | 133 | 1.600 |
Why?
|
| Liver Neoplasms | 3 | 2025 | 167 | 1.550 |
Why?
|
| Hepatitis C, Chronic | 2 | 2025 | 32 | 1.450 |
Why?
|
| Uropathogenic Escherichia coli | 2 | 2020 | 5 | 1.230 |
Why?
|
| Urinary Tract Infections | 2 | 2020 | 39 | 1.200 |
Why?
|
| Liver | 3 | 2025 | 471 | 1.120 |
Why?
|
| Hepacivirus | 3 | 2025 | 49 | 1.070 |
Why?
|
| Liver Cirrhosis | 1 | 2025 | 78 | 0.880 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2025 | 251 | 0.850 |
Why?
|
| Urinary Bladder | 2 | 2020 | 119 | 0.760 |
Why?
|
| Papillomavirus Infections | 1 | 2023 | 149 | 0.710 |
Why?
|
| Nanodiamonds | 2 | 2018 | 2 | 0.680 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2023 | 304 | 0.650 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2020 | 166 | 0.590 |
Why?
|
| Epithelial Cells | 1 | 2020 | 265 | 0.580 |
Why?
|
| Receptors, Estrogen | 2 | 2020 | 43 | 0.450 |
Why?
|
| NF-kappa B | 2 | 2017 | 191 | 0.440 |
Why?
|
| Immunity, Innate | 2 | 2025 | 231 | 0.340 |
Why?
|
| Bacteria, Aerobic | 1 | 2010 | 4 | 0.340 |
Why?
|
| Toll-Like Receptors | 1 | 2010 | 22 | 0.330 |
Why?
|
| Sex Factors | 2 | 2025 | 467 | 0.330 |
Why?
|
| Liver Diseases | 1 | 2010 | 52 | 0.320 |
Why?
|
| Disease Susceptibility | 2 | 2020 | 74 | 0.290 |
Why?
|
| Receptors, Androgen | 1 | 2008 | 26 | 0.290 |
Why?
|
| Female | 6 | 2025 | 15624 | 0.280 |
Why?
|
| Humans | 8 | 2025 | 28851 | 0.240 |
Why?
|
| Estrogens | 2 | 2020 | 56 | 0.240 |
Why?
|
| I-kappa B Kinase | 2 | 2017 | 8 | 0.220 |
Why?
|
| CD55 Antigens | 1 | 2023 | 2 | 0.210 |
Why?
|
| Middle Aged | 3 | 2025 | 7414 | 0.200 |
Why?
|
| Phosphorylation | 2 | 2017 | 585 | 0.200 |
Why?
|
| RNA, Messenger | 1 | 2025 | 668 | 0.200 |
Why?
|
| HeLa Cells | 1 | 2023 | 212 | 0.190 |
Why?
|
| Aged | 2 | 2025 | 5598 | 0.180 |
Why?
|
| Male | 4 | 2025 | 13921 | 0.170 |
Why?
|
| Adhesins, Escherichia coli | 1 | 2020 | 1 | 0.170 |
Why?
|
| Spectrum Analysis, Raman | 2 | 2018 | 32 | 0.170 |
Why?
|
| Menopause | 1 | 2020 | 30 | 0.170 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2020 | 87 | 0.160 |
Why?
|
| Transcription Factors | 1 | 2023 | 523 | 0.160 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 198 | 0.160 |
Why?
|
| Adult | 2 | 2025 | 8024 | 0.160 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 137 | 0.150 |
Why?
|
| Cells, Cultured | 1 | 2020 | 1022 | 0.140 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2018 | 82 | 0.140 |
Why?
|
| Colony Count, Microbial | 1 | 2018 | 82 | 0.140 |
Why?
|
| Cytoplasm | 1 | 2017 | 57 | 0.140 |
Why?
|
| Microscopy, Confocal | 1 | 2018 | 113 | 0.140 |
Why?
|
| In Vitro Techniques | 1 | 2018 | 242 | 0.130 |
Why?
|
| Cyclin D1 | 1 | 2017 | 38 | 0.130 |
Why?
|
| Cell Proliferation | 1 | 2020 | 824 | 0.130 |
Why?
|
| Cell Nucleus | 1 | 2017 | 138 | 0.130 |
Why?
|
| Pregnancy | 1 | 2020 | 1254 | 0.120 |
Why?
|
| Amoxicillin | 1 | 2016 | 6 | 0.120 |
Why?
|
| Cell Line | 1 | 2018 | 700 | 0.120 |
Why?
|
| Drug Carriers | 1 | 2016 | 119 | 0.110 |
Why?
|
| Animals | 2 | 2020 | 10684 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 536 | 0.090 |
Why?
|
| Mice | 1 | 2020 | 4802 | 0.080 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2010 | 10 | 0.080 |
Why?
|
| Gram-Positive Bacteria | 1 | 2010 | 33 | 0.080 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2010 | 34 | 0.080 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2010 | 72 | 0.080 |
Why?
|
| Fatty Liver | 1 | 2010 | 77 | 0.080 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2010 | 75 | 0.080 |
Why?
|
| Gene Expression | 1 | 2010 | 417 | 0.070 |
Why?
|
| Androgens | 1 | 2008 | 47 | 0.070 |
Why?
|
| Sex Characteristics | 1 | 2008 | 173 | 0.070 |
Why?
|
| Hepatitis B | 1 | 2007 | 13 | 0.070 |
Why?
|
| HLA Antigens | 1 | 2007 | 61 | 0.060 |
Why?
|
| Hepatitis C | 1 | 2007 | 42 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 1507 | 0.050 |
Why?
|
| Static Electricity | 1 | 2016 | 35 | 0.030 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2016 | 36 | 0.030 |
Why?
|
| Drug Liberation | 1 | 2016 | 29 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2016 | 73 | 0.030 |
Why?
|
| Polyethyleneimine | 1 | 2016 | 18 | 0.030 |
Why?
|
| Surface Properties | 1 | 2016 | 134 | 0.030 |
Why?
|
| Particle Size | 1 | 2016 | 105 | 0.030 |
Why?
|
| Hepatitis B virus | 1 | 2007 | 16 | 0.020 |
Why?
|
| Viral Vaccines | 1 | 2007 | 14 | 0.020 |
Why?
|
| Global Health | 1 | 2007 | 54 | 0.020 |
Why?
|
| Alleles | 1 | 2007 | 354 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2007 | 114 | 0.020 |
Why?
|